KR102328107B1 - Food composition comprising collagen peptides derived from Hibiscus - Google Patents
Food composition comprising collagen peptides derived from Hibiscus Download PDFInfo
- Publication number
- KR102328107B1 KR102328107B1 KR1020210028693A KR20210028693A KR102328107B1 KR 102328107 B1 KR102328107 B1 KR 102328107B1 KR 1020210028693 A KR1020210028693 A KR 1020210028693A KR 20210028693 A KR20210028693 A KR 20210028693A KR 102328107 B1 KR102328107 B1 KR 102328107B1
- Authority
- KR
- South Korea
- Prior art keywords
- hibiscus
- food composition
- collagen
- collagen peptide
- acid
- Prior art date
Links
- 108010035532 Collagen Proteins 0.000 title claims abstract description 70
- 102000008186 Collagen Human genes 0.000 title claims abstract description 70
- 229920001436 collagen Polymers 0.000 title claims abstract description 70
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 36
- 235000005206 Hibiscus Nutrition 0.000 title claims abstract description 33
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 title claims abstract description 33
- 235000013305 food Nutrition 0.000 title claims abstract description 25
- 241000218033 Hibiscus Species 0.000 title claims description 32
- 102000004196 processed proteins & peptides Human genes 0.000 title description 5
- 235000013311 vegetables Nutrition 0.000 claims abstract description 26
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 14
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 239000000284 extract Substances 0.000 claims description 21
- 108091005804 Peptidases Proteins 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 11
- 235000019419 proteases Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 102000004142 Trypsin Human genes 0.000 claims description 6
- 108090000631 Trypsin Proteins 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 239000012588 trypsin Substances 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 102000029816 Collagenase Human genes 0.000 claims description 2
- 108060005980 Collagenase Proteins 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 102000057297 Pepsin A Human genes 0.000 claims description 2
- 108090000284 Pepsin A Proteins 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 229960002424 collagenase Drugs 0.000 claims description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 2
- 239000011976 maleic acid Substances 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 229940111202 pepsin Drugs 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- 229960001322 trypsin Drugs 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 3
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 238000011084 recovery Methods 0.000 abstract description 4
- 230000001153 anti-wrinkle effect Effects 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 241001075721 Hibiscus trionum Species 0.000 abstract 1
- 230000006872 improvement Effects 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 230000005764 inhibitory process Effects 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 206010016256 fatigue Diseases 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 235000013376 functional food Nutrition 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 230000037303 wrinkles Effects 0.000 description 9
- 102000016387 Pancreatic elastase Human genes 0.000 description 8
- 108010067372 Pancreatic elastase Proteins 0.000 description 8
- 102000035195 Peptidases Human genes 0.000 description 8
- 230000002087 whitening effect Effects 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 210000002752 melanocyte Anatomy 0.000 description 7
- 230000009759 skin aging Effects 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 102000003425 Tyrosinase Human genes 0.000 description 6
- 108060008724 Tyrosinase Proteins 0.000 description 6
- 244000013123 dwarf bean Species 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 229960002591 hydroxyproline Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 150000002772 monosaccharides Chemical class 0.000 description 4
- 210000001626 skin fibroblast Anatomy 0.000 description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 206010024264 Lethargy Diseases 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 229940120503 dihydroxyacetone Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000000517 effect on sleep Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 102100036213 Collagen alpha-2(I) chain Human genes 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- SUHQNCLNRUAGOO-UHFFFAOYSA-N N-glycoloyl-neuraminic acid Natural products OCC(O)C(O)C(O)C(NC(=O)CO)C(O)CC(=O)C(O)=O SUHQNCLNRUAGOO-UHFFFAOYSA-N 0.000 description 1
- FDJKUWYYUZCUJX-UHFFFAOYSA-N N-glycolyl-beta-neuraminic acid Natural products OCC(O)C(O)C1OC(O)(C(O)=O)CC(O)C1NC(=O)CO FDJKUWYYUZCUJX-UHFFFAOYSA-N 0.000 description 1
- FDJKUWYYUZCUJX-KVNVFURPSA-N N-glycolylneuraminic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-KVNVFURPSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 식품 조성물에 관한 것으로, 더욱 상세하게는 히비스커스로부터 추출된 콜라겐 펩타이드를 유효성분으로 포함함으로써, 안전성 및 신뢰도가 우수하고, 인체 내의 흡수율이 높으며, 섭취 시 노화 및 주름 개선, 피로 회복 등의 효과가 우수한 히비스커스 콜라겐 펩타이드를 포함하는 식품 조성물에 관한 것이다. The present invention relates to a food composition, and more particularly, by including a collagen peptide extracted from hibiscus as an active ingredient, it has excellent safety and reliability, a high absorption rate in the human body, and improvement of aging and wrinkles upon ingestion, recovery from fatigue, etc. It relates to a food composition comprising a hibiscus collagen peptide having an excellent effect.
콜라겐은 동물의 몸속에 가장 많이 들어있는 섬유상 단백질로, 피부의 진피층과 결합조직의 주성분이며, 또한 뼈를 구성하고 있는 단백질 중 90%는 콜라겐이다. 일반적으로 의료용이나 화장품용, 식품용으로 사용되고 있는 콜라겐은 동물의 뼈와 피부에서 추출한 것으로 분자량 약 10만 가량의 폴리펩티드 사슬이 3개 모여 나선구조로 이루어진 고분자 단백질이다.Collagen is the most abundant fibrous protein in the body of animals, and is the main component of the dermal layer and connective tissue of the skin. Also, 90% of the proteins that make up bones are collagen. Collagen, which is generally used for medical, cosmetic, and food, is extracted from animal bones and skin.
콜라겐의 분자량은 대략 130,000정도이고, 포유동물의 조직(피부, 결합조직 그리고 뼈와 치아의 유기물질들의 주요 구성 요소)에서 1/3을 구성하고 있는 Polypeptide이다. 뼈의 mineral part들을 phosphoric acid를 가지고 용해시켜서 제조한다. The molecular weight of collagen is approximately 130,000, and it is a polypeptide that constitutes one third of the tissues of mammals (skin, connective tissue, and a major component of organic materials of bones and teeth). It is prepared by dissolving mineral parts of bone with phosphoric acid.
상기 콜라겐을 조직으로부터 분리하는 방법은, 유기용매추출, 산 알칼리처리 후 트립신, 히알루로니디아제를 작용시켜 불용성 물질인 콜라겐으로 얻는다. 구성 아미노산은 프롤린, 옥시프롤린(하이드록시프롤린), 글리신, 글루탐산 등이다.In the method of isolating the collagen from the tissue, it is obtained as an insoluble material, collagen, by applying trypsin and hyaluronidase after organic solvent extraction and acid-alkali treatment. The constituent amino acids are proline, oxyproline (hydroxyproline), glycine, and glutamic acid.
최근 노령인구의 급증으로 노화지연에 대한 연구가 활발히 이루어지고 있으며, 남녀노소 누구나 할 것 없이 젊음에 대한 갈망은 주체하기 어려울 정도이다. 이런 시대적인 붐을 타고 콜라겐의 효능 및 효과가 대두되면서 콜라겐을 찾는 사람들이 많아지고 있는 추세이다.Recently, research on aging delay has been actively conducted due to the rapid increase of the elderly population. As the efficacy and effect of collagen rise through the boom of the times, more and more people are looking for collagen.
특히, 기능성 식품 분야에서는 피부노화를 개선하기 위하여 콜라겐을 포함하는 기능성 식품 조성물이 다수 출시되었다. In particular, in the functional food field, a number of functional food compositions containing collagen have been released to improve skin aging.
그러나 현재 유통되고 있는 콜라겐의 대부분이 동물성이나 해양성 콜라겐이나, 구제역 및 광우병 등과 같은 질병이 돌고, 해양 오염 역시 심화되면서 동물성 및 해양성 콜라겐에 대한 불안감이 심화되어 신뢰도가 높지 못하다. 또한, 상기 동물성이나 해양성 콜라겐은 특유의 비린내로 인하여 섭취가 곤란하다는 문제가 있다.However, most of the collagen currently in circulation is animal or marine collagen, or diseases such as foot-and-mouth disease and mad cow disease circulate, and as marine pollution also deepens, anxiety about animal and marine collagen is deepened, so the reliability is not high. In addition, the animal or marine collagen has a problem in that it is difficult to ingest due to its unique fishy smell.
이에 따라 콜라겐의 주성분인 Hydroxy proline, proline, lysine 등이 들어 있는 식물성 단백질(이하 “식물성 콜라겐”이라 칭함)의 개발로 불안감을 안고 사용하던 동물성 및 해양성 콜라겐의 취약성을 보완할 필요성이 대두 되고 있다.Accordingly, the need to supplement the vulnerability of animal and marine collagen, which was used with anxiety with the development of plant proteins (hereinafter referred to as “vegetable collagen”) containing hydroxy proline, proline, and lysine, which are the main components of collagen, is emerging.
이러한 식물성 콜라겐을 포함하는 식품 조성물의 선행문헌으로는 대한민국 등록특허 제10-0827389호 및 대한민국 등록특허 제10-0488913호가 있다. 상기 선등록 특허들은 식물성 또는 해양성 원료로부터 콜라겐 펩타이드를 제조하는 방법을 제안하였으나, 선행문헌들의 어디에서도 히비스커스로부터 추출된 콜라겐 펩타이드를 포함하는 식품 조성물에 대해 찾아볼 수 없다.As a prior document of a food composition containing such vegetable collagen, there are Korean Patent Registration No. 10-0827389 and Korean Patent Registration No. 10-0488913. The previously registered patents suggest a method for producing collagen peptides from vegetable or marine raw materials, but there is no food composition containing collagen peptides extracted from hibiscus in any of the prior literatures.
따라서, 본 발명의 목적은 히비스커스로부터 추출된 식물성 콜라겐 펩타이드를 유효성분으로 포함함으로써, 비린내가 없어 섭취가 용이하고, 체내 콜라겐 합성을 촉진하여 피부 노화 및 주름을 개선하며, 피부 미백 효과 및 피로도 개선 효과를 갖는 식품 조성물을 제공하는 데 있다. Therefore, it is an object of the present invention to include vegetable collagen peptides extracted from hibiscus as an active ingredient, so there is no fishy smell, so it is easy to consume, promotes collagen synthesis in the body to improve skin aging and wrinkles, skin whitening effect and fatigue improvement effect To provide a food composition having.
본 발명의 다른 목적은 저분자 식물성 콜라겐 펩타이드를 통해 체내 흡수율이 우수한 식품 조성물을 제공하는 데 있다. Another object of the present invention is to provide a food composition having an excellent absorption rate in the body through a low molecular weight vegetable collagen peptide.
본 발명의 또 다른 목적은, 곰취 추출물 및 작두콩잎 추출물을 히비스커스로부터 추출된 식물성 콜라겐 펩타이드와 함께 포함함으로써, 체내 콜라겐 합성을 더욱 촉진하며, 피로도를 더욱 개선하는 식품 조성물을 제공하는 데 있다. Another object of the present invention is to provide a food composition that further promotes collagen synthesis in the body and further improves fatigue by including a gomchwi extract and a bean leaf extract together with a vegetable collagen peptide extracted from hibiscus.
상기한 목적을 달성하기 위한 본 발명의 식품 조성물은, 히비스커스로부터 추출된 식물성 콜라겐 펩타이드 유효성분으로 포함하는 것을 특징으로 한다.The food composition of the present invention for achieving the above object is characterized in that it comprises a vegetable collagen peptide active ingredient extracted from hibiscus.
상기 히비스커스로부터 추출된 식물성 콜라겐 펩타이드는, 중량평균분자량이 300~500달톤(Da)인 것을 특징으로 한다.The vegetable collagen peptide extracted from the hibiscus is characterized in that the weight average molecular weight is 300 to 500 Daltons (Da).
상기 히비스커스로부터 추출된 식물성 콜라겐 펩타이드는, 히비스커스의 열매, 꽃 또는 이들의 혼합물에 물을 가하고, 70~90℃에서 30~60분간 열처리하는 단계와, 상기 열처리된 처리물에 산성용액을 투입하고, 단백질분해효소를 첨가하여 40∼60℃로 2∼24시간 동안 가수분해하는 단계와, 상기 가수분해된 용액을 75~85℃로 가열하여 단백질분해효소를 실활시키는 단계를 포함하여 제조되는 것을 특징으로 한다.The vegetable collagen peptide extracted from the hibiscus, adding water to the fruit, flower or a mixture thereof, heat-treating at 70-90° C. for 30-60 minutes, and adding an acidic solution to the heat-treated product, It is characterized in that it is prepared by adding a protease to hydrolyze at 40 to 60° C. for 2 to 24 hours, and heating the hydrolyzed solution to 75 to 85° C. to inactivate the protease. do.
상기 유효성분으로 곰취 추출물 및 작두콩잎 추출물을 더 포함하는 것을 특징으로 한다.It is characterized in that it further comprises a gomchwi extract and a bean leaf extract as the active ingredient.
체내 콜라겐 합성을 촉진하는 것을 특징으로 한다.It is characterized by promoting collagen synthesis in the body.
본 발명의 히비스커스 콜라겐 펩타이드를 포함하는 식품 조성물에 의하면, 제품의 안정성 및 신뢰도가 우수하고, 비린내가 없어 섭취가 용이하며, 식물성 콜라겐 펩타이드의 체내 흡수율이 우수할 뿐만 아니라, 체내 콜라겐 합성을 촉진하여 노화 개선 및 주름 개선 효과가 우수하고, 피로 회복 효과가 우수하다는 장점이 있다.According to the food composition comprising the hibiscus collagen peptide of the present invention, the product has excellent stability and reliability, is easy to consume without a fishy smell, has excellent absorption rate of vegetable collagen peptide in the body, and promotes collagen synthesis in the body for aging It has the advantages of excellent improvement and anti-wrinkle effect, and excellent fatigue recovery effect.
도 1은 본 발명에 의한 시험예 2의 결과를 나타낸 그래프.
도 2는 본 발명에 의한 시험예 5의 결과를 나타낸 그래프.1 is a graph showing the results of Test Example 2 according to the present invention.
2 is a graph showing the results of Test Example 5 according to the present invention.
이하, 본 발명을 상세히 설명한다. Hereinafter, the present invention will be described in detail.
본 발명은 기능성 식품 조성물에 관한 것으로, 상기 기능성이란 콜라겐의 체내 합성을 촉진함으로써, 노화를 예방 및 개선하는 것, 또는 피로도를 개선하는 것을 의미한다. 본 발명에 의한 기능성 식품 조성물은, 히비스커스로부터 추출된 식물성 콜라겐 펩타이드를 유효성분으로 포함하는 것을 특징으로 한다.The present invention relates to a functional food composition, wherein the functionality refers to preventing and improving aging or improving fatigue by promoting the synthesis of collagen in the body. The functional food composition according to the present invention is characterized in that it contains a vegetable collagen peptide extracted from hibiscus as an active ingredient.
히비스커스(Hibiscus)는 쌍떡잎식물 아욱목 아욱과 무궁화속에 속하는 식물의 총칭으로, 인체 유효 생리 활성 물질이 함유되어 있어, 음용시 노폐물의 배설을 빠르게 배설시키며, 동맥경화, 항암성분, 장염, 기관지염 등에 효과가 있는 것으로 알려져 있다. 또한, 히비스커스 사브다리파 추출물 내 피루브산(pyruvic acid)은 DHA(dihydroxyacetone) 와 같이 음용하면 지방분해가 촉진되어 체중감소효과를 가지고 있을 뿐만 아니라 단백질 용해 작용을 지니는 것으로 알려져 있다. 또한, 상기 히비스커스는 피부 첩포(patch) 시 단백질을 용해하여 각질을 제거, 피부 재생률을 높이고, 활성산소를 차단하고 억제하여, 피부가 노화되는 것을 막아주고, 풍부한 비타민C 성분에 의해 기미나 주근깨와 같은 피부 트러블을 개선하여 피부 미용에 효과가 뛰어난 것으로 알려져 있다.Hibiscus is a generic term for plants belonging to the genus Mallow and Mugunghwa, which are dicotyledonous plants. It contains effective physiologically active substances for the human body, so it rapidly excretes wastes when drinking, and is effective for arteriosclerosis, anticancer ingredients, enteritis, bronchitis, etc. is known to have In addition, pyruvic acid in the hibiscus sabdaripa extract is known to have a protein dissolution effect as well as a weight loss effect by promoting lipolysis when consumed with DHA (dihydroxyacetone). In addition, the hibiscus dissolves proteins during skin patching to remove dead skin cells, increase the skin regeneration rate, block and inhibit active oxygen, prevent skin aging, and prevent blemishes and freckles due to the abundant vitamin C component It is known to be effective in skin beauty by improving the same skin troubles.
본 발명은 이러한 히비스커스로부터 콜라겐을 추출하고, 가수분해하여 콜라겐 펩타이드를 제조하고, 이를 식품 조성물에 포함시킴으로써, 안전성 및 신뢰도가 우수하며, 체내 흡수율이 우수함은 물론, 콜라겐의 체내 합성을 촉진하여 피부 노화 및 주름을 개선하고, 미백 효과를 부여하고, 피로 회복 역시 촉진하는 식품 조성물을 제공하는 데 특징이 있다.The present invention extracts collagen from the hibiscus, hydrolyzes it to prepare a collagen peptide, and includes it in a food composition, so that it has excellent safety and reliability, excellent absorption rate in the body, and promotes the synthesis of collagen in the body for skin aging And it is characterized by providing a food composition that improves wrinkles, imparts a whitening effect, and also promotes recovery from fatigue.
상기 히비스커스로부터 식물성 콜라겐 펩타이드를 제조하는 방법은, 히비스커스의 열매, 꽃 또는 이들의 혼합물에 물을 가하고, 70~90℃에서 30~60분간 열처리하는 단계와, 상기 열처리된 처리물에 산성용액을 투입하고, 단백질분해효소를 첨가하여 40∼60℃로 2∼24시간 동안 가수분해하는 단계와, 상기 가수분해된 용액을 75~85℃로 가열하여 단백질분해효소를 실활시키는 단계를 포함한다.The method for producing a vegetable collagen peptide from the hibiscus includes the steps of adding water to the fruit, flower or mixture thereof of hibiscus, and heat-treating it at 70-90° C. for 30-60 minutes, and adding an acidic solution to the heat-treated product and adding a protease to hydrolyze at 40 to 60° C. for 2 to 24 hours, and heating the hydrolyzed solution to 75 to 85° C. to inactivate the protease.
이를 보다 구체적으로 설명하면, 먼저 원료물질은 히비스커스의 열매, 꽃 또는 이들의 혼합물을 세척하여 준비한다. 그리고 이에 3~5중량배의 물을 가하고, 파쇄기로 초핑한다. 이때, 그 크기는 10~200㎛ 정도면 족한바 그 크기를 제한하지 않는다. To explain this in more detail, first, the raw material is prepared by washing the fruit, flower, or mixture thereof of hibiscus. Then, 3 to 5 times by weight of water is added thereto, and it is chopped with a crusher. At this time, the size is not limited to about 10 ~ 200㎛ bar is sufficient.
다음으로, 이를 70~100℃에서 30~60분간 열처리한다. 그리고 열처리한 처리물에 초산, 사과산, 마레인산, 호박산, 구연산 중 1종 이상의 유기산을 첨가하여 pH를 3.0~6.0로 조절한다. 상기 열처리물은 강산 상태가 아닌 약산 상태에서도 쉽게 가수분해가 가능하므로, pH를 3.0~6.0 정도로 조절하는 것이다. Next, it is heat-treated at 70-100° C. for 30-60 minutes. Then, one or more organic acids of acetic acid, malic acid, maleic acid, succinic acid, and citric acid are added to the heat-treated product to adjust the pH to 3.0 to 6.0. Since the heat-treated product can be easily hydrolyzed even in a weak acid state rather than a strong acid state, the pH is adjusted to about 3.0 to 6.0.
그리고 이에 콜라게나아제, 트립신, 파파인, 펩신 및 알칼라제로 이루어진 군에서 선택되는 1종 이상의 단백질분해효소를 첨가하고, 40~60℃에서 2~24시간 동안 가수분해한다. 이는 상기 범위의 온도 및 시간의 조건하에 가수분해 반응이 일어나는 경우 체내 흡수율이 높은 적절한 분자량 및 크기의 콜라겐 펩타이드를 얻을 수 있기 때문이다.Then, at least one proteolytic enzyme selected from the group consisting of collagenase, trypsin, papain, pepsin and alcalase is added thereto, and hydrolyzed at 40 to 60° C. for 2 to 24 hours. This is because, when the hydrolysis reaction occurs under the conditions of temperature and time in the above range, it is possible to obtain a collagen peptide having an appropriate molecular weight and size having a high absorption rate in the body.
이때, 상기 단백질분해효소의 첨가량은 종래 이 기술이 속하는 분야에서 공지된 정도의 양이면 족한바, 이를 제한하지 않는다.In this case, the added amount of the protease is sufficient as long as it is an amount known in the art to which this technology belongs, and is not limited thereto.
다음으로, 상기 가수분해된 용액을 75~85℃로 10~60분간 가열하여 단백질분해효소를 실활시킨다. 그리고 이를 여과한다. 여기서, 상기 여과방법은 제한하지 않는다.Next, the hydrolyzed solution is heated at 75 to 85° C. for 10 to 60 minutes to inactivate the protease. and filter it. Here, the filtration method is not limited.
그리고 필요에 따라 이를 농축 또는 건조한다.And if necessary, it is concentrated or dried.
상기와 같이 제조된 히비스커스로부터 추출된 식물성 콜라겐 펩타이드는, 중량평균분자량이 300~500달톤(Da)으로, 체내 흡수율이 현저히 높으며, 프롤린, 하이드록시프롤린, 라이신 등의 성분이 풍부하여 체내 콜라겐의 합성을 효과적으로 촉진하며, 우수한 노화 개선, 주름 개선 및 미백 활성, 그리고 피로 개선의 효과를 나타낸다.The vegetable collagen peptide extracted from the hibiscus prepared as described above has a weight average molecular weight of 300 to 500 Daltons (Da), has a remarkably high absorption rate in the body, and is rich in components such as proline, hydroxyproline, and lysine to synthesize collagen in the body. It effectively promotes skin aging and exhibits excellent anti-aging, anti-wrinkle and whitening activity, and improvement of fatigue.
이때, 상기 히비스커스로부터 추출된 식물성 콜라겐 펩타이드는 섬유아세포의 콜라겐 합성을 촉진함으로써, 결과적으로 피부 탄력, 주름 개선 등의 효과를 부여하며, 피부 노화를 개선하는 것이다.At this time, the vegetable collagen peptide extracted from the hibiscus promotes collagen synthesis in fibroblasts, and consequently gives effects such as skin elasticity and wrinkle improvement, and improves skin aging.
한편, 본 발명은 상기 유효성분으로 곰취 추출물 및 작두콩잎 추출물을 더 포함할 수 있다.Meanwhile, the present invention may further include gomchwi extract and green bean leaf extract as the active ingredient.
상기 곰취 추출물 및 작두콩잎 추출물을 더 포함하면 섬유아세포의 콜라겐 합성을 더욱 촉진함으로써, 히비스커스로부터 추출된 식물성 콜라겐 펩타이드의 효과가 배가된다. When the gomchwi extract and green bean leaf extract are further included, the effect of the vegetable collagen peptide extracted from hibiscus is doubled by further promoting collagen synthesis in fibroblasts.
이때, 상기 곰취 추출물 및 작두콩잎 추출물은, 곰취잎 또는 작두콩잎을 물, 탄소수 1 내지 4의 알코올 중 1종 이상의 것을 추출용매로하여 추출한 것임이 바람직하며, 그 추출방법은 종래 게시된 다양한 방법에 의하는 것으로, 이를 제한하지 않는다.At this time, it is preferable that the Gomchwi extract and the soybean leaf extract are extracted from the gomchwi leaf or the soybean leaf extract using at least one of water and alcohol having 1 to 4 carbon atoms as an extraction solvent, and the extraction method is based on various methods previously published. according to, but not limited to.
그리고 상기 히비스커스 콜라겐 펩타이드, 곰취 추출물 및 작두콩잎 추출물은 고형분 기준 1:0.1~1:0.1~1 중량비로 포함될 수 있는바, 이는 우수한 섬유아세포의 콜라겐 합성 촉진을 위한 것이다.In addition, the hibiscus collagen peptide, gomchwi extract and green bean leaf extract may be included in a weight ratio of 1:0.1 to 1:0.1 to 1 based on solid content, which is to promote excellent fibroblast collagen synthesis.
한편, 본 발명의 상기 식품 조성물은 특별히 제한되지 아니하며, 건강 기능 식품 조성물을 포함한다. 본 발명의 상기 건강 기능 식품 조성물을 식품 첨가물로 사용할 경우, 상기 조성물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 상기 식품의 종류는 특별히 제한되지 아니하며, 통상적인 의미에서의 식품을 모두 포함한다. 상기 물질을 첨가할 수 있는 식품의 비제한적인 예로는 육류, 소세지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올 음료 및 비타민 복합제 등을 들 수 있다.On the other hand, the food composition of the present invention is not particularly limited, and includes a health functional food composition. When the health functional food composition of the present invention is used as a food additive, the composition may be added as it is or used together with other foods or food ingredients, and may be appropriately used according to a conventional method. The type of the food is not particularly limited, and includes all foods in the ordinary sense. Non-limiting examples of foods to which the above substances can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea , drinks, alcoholic beverages, and vitamin complexes.
본 발명의 상기 건강 기능 식품 조성물이 음료 조성물인 경우, 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물의 비제한적인 예로 포도당, 과당과 같은 모노사카라이드; 말토스, 수크로오스와 같은 디사카라이드; 덱스트린, 사이클로덱스트린과 같은 천연 감미제; 사카린, 아스파르탐과 같은 합성 감미제 등을 들 수 있다. 상기 첨가되는 추가 성분의 비율은 당업자의 선택에 의해 적절하게 결정될 수 있다.When the health functional food composition of the present invention is a beverage composition, it may contain various flavoring agents or natural carbohydrates as an additional component like a conventional beverage. Non-limiting examples of the natural carbohydrate include monosaccharides such as glucose and fructose; disaccharides such as maltose and sucrose; natural sweeteners such as dextrin and cyclodextrin; and synthetic sweeteners such as saccharin and aspartame. The proportion of the additional components to be added may be appropriately determined by the selection of those skilled in the art.
상기 외에 본 발명의 건강 기능 식품 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 건강 기능 식품 조성물은 천연 과일 주스, 과일 음료 또는 야채 음료 등의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 사용되거나 2 이상을 조합하여 사용할 수 있다. 이러한 첨가물의 비율 또한 당업자에 의해 적절히 선택될 수 있다.In addition to the above, the health functional food composition of the present invention includes various nutrients, vitamins, electrolytes, flavoring agents, colorants, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin , alcohol, carbonation agents used in carbonated beverages, and the like. In addition, the health functional food composition of the present invention may contain the pulp for the production of natural fruit juice, fruit drink or vegetable drink. These components may be used independently or in combination of two or more. The proportion of these additives may also be appropriately selected by those skilled in the art.
본 발명의 식품 조성물은 연령, 체중에 따라 적량을 선택하여 섭취할 수 있다.The food composition of the present invention can be ingested by selecting an appropriate amount according to age and weight.
이하, 실시예를 통해 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail through examples.
(실시예 1)(Example 1)
히비스커스의 열매 1kg에 4L의 물을 가하고, 분쇄기로 10~100㎛의 크기로 분쇄하고, 80℃에서 60분간 열처리하였다. 4L of water was added to 1 kg of hibiscus fruit, crushed to a size of 10-100 μm with a grinder, and heat-treated at 80° C. for 60 minutes.
그리고 이 열처리물에 사과산을 투입하여 pH를 3.5로 조절하고, 단백질분해효소로 트립신 5g을 첨가하여 50℃로 10시간 동안 가수분해하고, 이를 80℃로 30분간 가열하여 트립신을 실활시키고, 원심분리기에서 1000rpm에서 30분 동안 교반하여 히비스커스 유래 식물성 콜라겐 펩타이드를 제조하였다. 그리고 이를 동결건조하였다.Then, malic acid was added to the heat-treated product to adjust the pH to 3.5, and 5 g of trypsin was added as a proteolytic enzyme, hydrolyzed at 50° C. for 10 hours, and heated at 80° C. for 30 minutes to inactivate trypsin, and centrifuge. A hibiscus-derived vegetable collagen peptide was prepared by stirring at 1000 rpm for 30 minutes. And it was freeze-dried.
(실시예 2)(Example 2)
곰취의 잎을 깨끗이 세척하고, 동결건조하였다. 그리고 건조된 곰취의 잎에 5중량배의 70% 에탄올 수용액을 가하고, 50℃에서 10시간 추출하고, 이를 여과, 농축 및 동결건조하여 곰취 추출물을 제조하였다.The leaves of Gomchwi were thoroughly washed and lyophilized. Then, 5 weight times of 70% ethanol aqueous solution was added to the dried leaves of Gomchwi, extracted at 50° C. for 10 hours, and filtered, concentrated and freeze-dried to prepare an extract of Gomchwi.
또한, 작두콩잎 역시 상기 곰취잎과 동일한 방법으로 추출하여 작두콩잎 추출물을 제조하였다. In addition, the green bean leaf was also extracted in the same way as the Gomchwi leaf to prepare a green bean leaf extract.
그리고 실시예 1에서 제조된 식물성 콜라겐 펩타이드와 상기 곰취 추출물 및 작두콩잎 추출물을 1:0.5:0.5 중량비로 혼합하였다.And the vegetable collagen peptide prepared in Example 1, the Gomchwi extract and the green bean leaf extract were mixed in a weight ratio of 1:0.5:0.5.
(시험예 1)(Test Example 1)
상기 실시예 1에서 제조된 식물성 콜라겐 펩타이드의 아미노산 분석을 실시하였다. 아미노산(Total amino acid) 분석은 Total amino acid composition & OH-Proline analysis방법을 적용하였다. 그리고 이와 함께 단당류 분석을 실시하였다. 그 결과는 하기 표 1 및 표 2에 나타내었다.Amino acid analysis of the vegetable collagen peptide prepared in Example 1 was performed. Total amino acid composition & OH-Proline analysis method was applied for amino acid analysis. In addition, monosaccharide analysis was performed. The results are shown in Tables 1 and 2 below.
상기 표 1, 2에서와 같이 실시예 1의 시료는 하이드록시 프롤린, 라이신, 프롤린 등이 풍부하게 함유됨을 확인하였으며, 글루탐산, 아스파르트산, 아르기닌 등이 풍부하여 피부 노화 방지에 유용하며, 단당류를 소량 포함함을 확인할 수 있었다.As shown in Tables 1 and 2, it was confirmed that the sample of Example 1 contains abundant hydroxyproline, lysine, proline, etc., and is useful for skin aging prevention because it is rich in glutamic acid, aspartic acid, arginine, etc., and contains a small amount of monosaccharides. could be confirmed to be included.
(시험예 2)(Test Example 2)
상기 실시예 1에서 제조된 식물성 콜라겐 펩타이드의 분자량을 측정하였다. 그리고 그 결과를 도 1에 나타내었다. The molecular weight of the vegetable collagen peptide prepared in Example 1 was measured. And the result is shown in FIG.
도 1에서 확인할 수 있는 바와 같이, 식물성 콜라겐 펩타이드의 중량평균분자량이 440Da임을 확인하여 흡수율이 우수할 것으로 판단되었다.As can be seen in FIG. 1 , it was confirmed that the weight average molecular weight of the vegetable collagen peptide was 440 Da, and it was determined that the absorption rate was excellent.
(시험예 3)(Test Example 3)
시료의 피부 미백 효능을 확인하기 위해, B16-F10 멜라닌 세포에 여러 가지 농도의 시료를 처리한 후, 티로시나아제(tyrosinase) 저해 활성을 측정하였다.In order to confirm the skin whitening effect of the sample, B16-F10 melanocytes were treated with samples at various concentrations, and then, tyrosinase inhibitory activity was measured.
시험을 위한 멜라닌 세포를 준비하고자, 24 웰 플레이트에 B16-F10 멜라닌 세포(제조사 ATCC LOT 60508145) 상등액(50,000 cells/well)을 500㎕씩 분주하고 37℃ 및 5% CO2 조건에서 24시간 동안 pre-incubation 시켜 세포를 well plate에 부착시켰다.To prepare melanocytes for the test, 500 μl of the supernatant (50,000 cells/well) of B16-F10 melanocytes (manufacturer ATCC LOT 60508145) was dispensed in a 24-well plate and pre- After incubation, the cells were attached to the well plate.
다음으로, 실시예 1, 2, 양성대조군으로 비타민 C 각각을 물에 희석하여 0.2mg/ml, 1.0mg/ml, 5.0mg/ml 농도의 시료를 제조한 후, 각 웰에 50㎕씩 분주하고 37℃ 및 5% CO2 조건에서 24시간 동안 인큐베이션하였다. 이어서, 1mg/ml 트립신(trypsin)을 10㎕처리하고 10분 동안 반응시킨 후, 1000rpm에서 약 2분 동안 원심분리시켜 펠렛을 얻었다. 이로부터 얻은 펠렛을 1% triton X-100 PBS 0.5ml 용액에 용해시켰으며, 0.2% L-DOPA 01M 소듐 포스페이트 버퍼(Sodium phosphate buffer)를 0.5ml 혼합한 후에 37℃에서 2시간동안 배양시키고, 490nm의 빛을 조사해 흡광도를 측정하였다. 티로시나아제 저해율은 아래 식을 이용해 계산하였으며, 티로시나아제 저해율 측정결과를 하기 표 3에 나타내었다.Next, in Examples 1 and 2, each of vitamin C as a positive control group was diluted in water to prepare samples with concentrations of 0.2 mg/ml, 1.0 mg/ml, and 5.0 mg/ml, and then 50 μl of each was dispensed into each well. Incubated for 24 hours at 37° C. and 5% CO 2 conditions. Then, 10 μl of 1 mg/ml trypsin was treated and reacted for 10 minutes, and then centrifuged at 1000 rpm for about 2 minutes to obtain a pellet. The pellet obtained therefrom was dissolved in 0.5ml solution of 1% triton X-100 PBS, and 0.5ml of 0.2% L-DOPA 01M sodium phosphate buffer was mixed and incubated at 37°C for 2 hours, 490nm The absorbance was measured by irradiating the light. The tyrosinase inhibition rate was calculated using the following formula, and the tyrosinase inhibition rate measurement results are shown in Table 3 below.
티로시나아제 활성 저해율(%)={(대조군의 흡광도-시료 첨가군의 흡광도)/대조군의 흡광도} × 100Tyrosinase activity inhibition rate (%) = {(absorbance of control group - absorbance of sample addition group) / absorbance of control group} × 100
상기 표 3에서와 같이, 실시예 1 및 2는 티로시나아제 활성 저해율이 우수함을 확인할 수 있어, 미백 효과가 있는 것으로 판단되었다.As shown in Table 3, Examples 1 and 2 can confirm that the tyrosinase activity inhibition rate is excellent, it was determined that there is a whitening effect.
(시험예 4)(Test Example 4)
시료의 피부 주름 개선 효과를 확인하기 위해, B16-F10 멜라닌 세포에 여러 가지 농도의 시료를 처리한 후, 엘라스타아제(Elastase) 활성 저해율을 측정하였다.In order to confirm the skin wrinkle improvement effect of the sample, the B16-F10 melanocytes were treated with samples at various concentrations, and then the elastase activity inhibition rate was measured.
시험을 위한 멜라닌 세포를 준비하고자, 24 웰 플레이트에 B16-F10 멜라닌 세포(제조사 ATCC LOT 60508145) 상등액(50,000 cells/well)을 500㎕씩 분주하고 37℃, 5% CO2조건에서 24시간 동안 pre-incubation 시켜 세포를 웰 플레이트에 부착시켰다.To prepare melanocytes for the test, 500 μl of the supernatant (50,000 cells/well) of B16-F10 melanocytes (manufacturer ATCC LOT 60508145) was dispensed in a 24-well plate, and pre- After incubation, the cells were attached to the well plate.
다음으로, 실시예 1, 실시예 2, 양성대조군으로 비타민 C 각각을 물에 희석하여 0.2mg/ml, 1.0mg/ml, 5.0mg/ml 농도의 시료를 제조한 후, 각 웰에 10㎕씩 분주한 후, 50mM tris-HCl 버퍼(pH 8.6)에 녹인 porcine pancreas elastase(10㎍/mL)용액을 50㎕씩 첨가하고 기질로 50mM tris-HCl buffer (pH 8.6)에 녹인 N-succinyl-(L-Ala)3-p-nitroanilide (0.5mg/mL)을 100㎕씩 첨가한 후, 20분간 반응시킨 다음 B16-F10 멜라닌 세포의 엘라스타아제 활성 저해율을 측정하였다. 엘라스타아제 활성 저해율은 시료용액의 첨가구와 무첨가구의 흡광도 감소율을 측정하고, 하기 식에 의해 엘라스타아제 활성 저해율을 계산한 후, 그 결과를 하기 표 4에 나타내었다. Next, in Examples 1 and 2, as a positive control, each of vitamin C was diluted in water to prepare samples having concentrations of 0.2 mg/ml, 1.0 mg/ml, and 5.0 mg/ml, and then, 10 μl of each well After dispensing, 50 μl of porcine pancreas elastase (10 μg/mL) solution dissolved in 50 mM tris-HCl buffer (pH 8.6) was added at a time, and N-succinyl-(L) dissolved in 50 mM tris-HCl buffer (pH 8.6) as a substrate. -Ala)3-p-nitroanilide (0.5mg/mL) was added by 100 μl each, followed by reaction for 20 minutes, and then the elastase activity inhibition rate of B16-F10 melanocytes was measured. The elastase activity inhibition rate was measured by measuring the absorbance reduction rate of the group with and without the addition of the sample solution, and the elastase activity inhibition rate was calculated by the following formula, and the results are shown in Table 4 below.
엘라스타아제 활성 저해율(%)=(1-시료첨가군의 흡광도/무첨가군의 흡광도) × 100Elastase activity inhibition rate (%) = (1-absorbance of sample added group / absorbance of no-addition group) × 100
상기 표 4에서와 같이, 실시예 1 및 2는 엘라스타제 활성 저해율이 우수함을 확인할 수 있어, 주름 개선 효과가 있는 것으로 판단되었다.As shown in Table 4, Examples 1 and 2 can confirm that the elastase activity inhibition rate is excellent, it was determined that there is a wrinkle improvement effect.
(시험예 5)(Test Example 5)
사람 피부섬유아세포를 10% Fetal Bovine Serum과 1%의 페니실린과 스트렙토마이신이 첨가된 Dulbeccos's Minimum Essential Medium에 배양하여 계대수 5 이하를 유지하며, 상기 실시예 1, 2의 처리에 따른 콜라겐 합성량의 변화를 생체 외(in vitro 상)에서 실험하여, 사람 피부섬유아세포의 콜라겐 합성 촉진 효과를 평가하였다. 또한, 비교예로서 무처리된 DMEM 배지를 준비하여 비교하였다.Human skin fibroblasts were cultured in Dulbeccos' Minimum Essential Medium supplemented with 10% Fetal Bovine Serum and 1% penicillin and streptomycin to maintain a passage number of 5 or less, and the amount of collagen synthesis according to the treatment of Examples 1 and 2 The change was tested in vitro to evaluate the collagen synthesis promoting effect of human dermal fibroblasts. In addition, as a comparative example, an untreated DMEM medium was prepared and compared.
시료별로 사람 피부섬유아세포를 웰 플레이트(well plate)에 1×104cells/㎠의 밀도로 seeding한 후 세포 부착과 환경 적응을 위해 24시간 동안 인큐베이터(incubator)(37°C, 5% CO2)에서 배양하였다. 그리고 배지를 제거한 후, 혈청(Serum)이 첨가되지 않은 배지를 처리하여 8시간 동안 starvation시켰다. 상기 실시예 조성물을 배지에 용해하여 시료별로 처리하였다. 시료 처리 후, 사람 피부 섬유아세포를 72시간 동안 배양하고 배지의 상층액을 취하여 합성된 콜라겐을 정량하였다. 콜라겐 정량은 타입 1 프로콜라겐 C-펩타이드EIA 키트(Type I Procollagen C-Peptide EIA kit)(Takara, Japan)를 사용하였다. 그 결과는 도 2에 나타내었다. For each sample, human skin fibroblasts were seeded in a well plate at a density of 1×10 4 cells/cm2 and then placed in an incubator (37°C, 5% CO2) for 24 hours for cell adhesion and environmental adaptation. cultured in After removing the medium, the medium was treated with no serum and starvated for 8 hours. The composition of the above example was dissolved in the medium and treated for each sample. After sample treatment, human skin fibroblasts were cultured for 72 hours and the supernatant of the medium was taken to quantify the synthesized collagen. Collagen quantification was performed using a Type I Procollagen C-Peptide EIA kit (Takara, Japan). The results are shown in FIG. 2 .
도 2에서와 같이, 본 발명의 실시예 1, 2는 사람 피부섬유아세포의 콜라겐 합성을 촉진하는 것을 확인할 수 있었다.As shown in FIG. 2 , it was confirmed that Examples 1 and 2 of the present invention promote collagen synthesis in human skin fibroblasts.
(제조예 1)(Production Example 1)
실시예 1의 시료 10중량%와 말토덱스트린 90중량%를 혼합하고, 정제로 제형화하였다.10% by weight of the sample of Example 1 and 90% by weight of maltodextrin were mixed and formulated into tablets.
(제조예 2)(Production Example 2)
실시예 2의 시료 10중량%와 말토덱스트린 90중량%를 혼합하고, 정제로 제형화하였다.10% by weight of the sample of Example 2 and 90% by weight of maltodextrin were mixed and formulated into tablets.
(시험예 6)(Test Example 6)
제조예 1 및 2의 시료별로 10명씩 10~60대의 남녀에게 30일간 매일 하루에 2번 10g씩 식후에 복용하게 하였으며, 30일간의 복용 후, 피로감 개선 정도를 하기 표 4에 5점 타점법(5점 : 아주 우수함, 4점 : 우수함, 3점 : 보통, 2점 : 나쁨, 1점 : 아주나쁨)으로 나타내게 하였다. 이를 통해, 숙면 효과, 무기력감 개선 효과, 전체적인 피로감 개선 효과 등을 확인하였다. 대조군으로는 시판 비타민 C를 제공하였다. 그 결과는 하기 표 5에 나타내었다.For each sample of Preparation Examples 1 and 2, 10 men and women in their 10s and 60s were to take 10 g twice a day for 30 days after meals, and after taking 30 days, the degree of fatigue improvement is shown in Table 4 below using the 5-point scoring method ( 5 points: very good, 4 points: excellent, 3 points: average, 2 points: poor, 1 point: very poor). Through this, a sound sleep effect, an effect of improving the feeling of lethargy, and an effect of improving the overall feeling of fatigue were confirmed. Commercially available vitamin C was provided as a control group. The results are shown in Table 5 below.
상기 표 5에서와 같이, 본 발명의 제조예 1, 2는 피로감을 개선함을 확인할 수 있었다.As shown in Table 5, it was confirmed that Preparation Examples 1 and 2 of the present invention improved the feeling of fatigue.
(시험예 7)(Test Example 7)
제조예 1 및 2의 시료별로 15명씩 50대의 여성에게 30일간 매일 하루에 2번 10g씩 식후에 복용하게 하였으며, 30일간의 복용 후, 주름 개선, 미백 개선 정도를 살펴보았다. 그리고 그 결과를 하기 표 6에 나타내었다. For each sample of Preparation Examples 1 and 2, 15 women in their 50s were given 10 g twice a day for 30 days after meals, and after 30 days of taking, wrinkle improvement and whitening improvement were examined. And the results are shown in Table 6 below.
개선wrinkle
Improving
개선Whitening
Improving
상기 표 6에서와 같이, 제조예 1, 2는 주름 개선 및 미백에 효과가 있음을 확인할 수 있었다. As shown in Table 6, it was confirmed that Preparation Examples 1 and 2 were effective in wrinkle improvement and whitening.
또한, 복용시 비린내 유,무에 대해 조사하였으나, 모두 별다른 이취를 느끼지 못했다고 답변하였는바, 섭취 역시 용이하다는 장점이 있었다. In addition, they investigated whether there was a fishy smell when taking it, but all answered that they did not feel any particular odor, so it had the advantage of being easy to ingest.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.The description of the present invention described above is for illustration, and those of ordinary skill in the art to which the present invention pertains can understand that it can be easily modified into other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, it should be understood that the embodiments described above are illustrative in all respects and not restrictive.
Claims (5)
상기 히비스커스로부터 추출된 식물성 콜라겐 펩타이드는,
히비스커스의 열매, 꽃 또는 이들의 혼합물에 3~5중량배의 물을 가하고, 70~90℃에서 30~60분간 열처리하는 단계;
상기 열처리된 처리물에 유기산을 투입하여 pH를 3.0~6.0으로 조절하고, 단백질분해효소를 첨가하여 40∼60℃로 2∼24시간 동안 가수분해하는 단계;
상기 가수분해된 용액을 75~85℃로 가열하여 단백질분해효소를 실활시키는 단계;를 포함하여 제조되며,
유효성분으로 곰취 추출물 및 작두콩잎 추출물을 더 포함하는 것을 특징으로 하는 히비스커스 콜라겐 펩타이드를 포함하는 식품 조성물.
Contains as an active ingredient of vegetable collagen peptide extracted from hibiscus,
The vegetable collagen peptide extracted from the hibiscus,
adding 3 to 5 times by weight of water to hibiscus fruits, flowers, or a mixture thereof, and heat-treating at 70 to 90° C. for 30 to 60 minutes;
adjusting the pH to 3.0 to 6.0 by adding an organic acid to the heat-treated product, and hydrolyzing at 40 to 60° C. for 2 to 24 hours by adding a protease;
It is prepared including; heating the hydrolyzed solution to 75 ~ 85 ℃ to inactivate the protease,
A food composition comprising a hibiscus collagen peptide, characterized in that it further comprises a gomchwi extract and a bean leaf extract as active ingredients.
상기 히비스커스로부터 추출된 식물성 콜라겐 펩타이드는,
중량평균분자량이 300~500달톤(Da)인 것을 특징으로 하는 히비스커스 콜라겐 펩타이드를 포함하는 식품 조성물.
According to claim 1,
The vegetable collagen peptide extracted from the hibiscus,
A food composition comprising a hibiscus collagen peptide, characterized in that the weight average molecular weight is 300 to 500 Daltons (Da).
상기 유기산은 초산, 사과산, 마레인산, 호박산, 구연산 중 1종 이상을 포함하고,
상기 단백질분해효소는 콜라게나아제, 트립신, 파파인, 펩신 및 알칼라제로 이루어진 군에서 선택되는 1종 이상을 포함하는 것을 특징으로 하는 히비스커스 콜라겐 펩타이드를 포함하는 식품 조성물.
According to claim 1,
The organic acid includes at least one of acetic acid, malic acid, maleic acid, succinic acid, and citric acid,
The protease is a food composition comprising a hibiscus collagen peptide, characterized in that it comprises one or more selected from the group consisting of collagenase, trypsin, papain, pepsin, and alkalinease.
체내 콜라겐 합성을 촉진하는 것을 특징으로 하는 히비스커스 콜라겐 펩타이드를 포함하는 식품 조성물.4. The method according to any one of claims 1 to 3,
A food composition comprising a hibiscus collagen peptide, characterized in that it promotes collagen synthesis in the body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210028693A KR102328107B1 (en) | 2021-03-04 | 2021-03-04 | Food composition comprising collagen peptides derived from Hibiscus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210028693A KR102328107B1 (en) | 2021-03-04 | 2021-03-04 | Food composition comprising collagen peptides derived from Hibiscus |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102328107B1 true KR102328107B1 (en) | 2021-11-18 |
Family
ID=78717211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210028693A KR102328107B1 (en) | 2021-03-04 | 2021-03-04 | Food composition comprising collagen peptides derived from Hibiscus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102328107B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102565639B1 (en) | 2023-01-31 | 2023-08-11 | 주식회사 창의씨앤알 | Plant derived collagen peptide composition and composition comprising the same |
KR102576286B1 (en) | 2023-02-10 | 2023-09-13 | (주)로가 | Manufacturing method of collagen peptides derived from plants |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100488913B1 (en) | 2003-05-21 | 2005-05-11 | 장부식 | A method of vegiterble and marin collagen peptide |
KR20060087817A (en) * | 2005-01-31 | 2006-08-03 | 주식회사 태평양 | Anti-aging cosmetic composition |
KR100827389B1 (en) | 2007-01-02 | 2008-05-06 | 씨엔에이바이오텍(주) | Composition of collagen peptides for food and method thereof |
KR20110117376A (en) * | 2010-04-21 | 2011-10-27 | (주)아모레퍼시픽 | Composition containing red sword bean extract for anti-aging and whitening |
KR20200090628A (en) * | 2019-01-21 | 2020-07-29 | 주식회사 브라이언스랩 | Hibiscus extracts containing food composition thereof and preparation method of the hibiscus extracts |
-
2021
- 2021-03-04 KR KR1020210028693A patent/KR102328107B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100488913B1 (en) | 2003-05-21 | 2005-05-11 | 장부식 | A method of vegiterble and marin collagen peptide |
KR20060087817A (en) * | 2005-01-31 | 2006-08-03 | 주식회사 태평양 | Anti-aging cosmetic composition |
KR100827389B1 (en) | 2007-01-02 | 2008-05-06 | 씨엔에이바이오텍(주) | Composition of collagen peptides for food and method thereof |
KR20110117376A (en) * | 2010-04-21 | 2011-10-27 | (주)아모레퍼시픽 | Composition containing red sword bean extract for anti-aging and whitening |
KR20200090628A (en) * | 2019-01-21 | 2020-07-29 | 주식회사 브라이언스랩 | Hibiscus extracts containing food composition thereof and preparation method of the hibiscus extracts |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102565639B1 (en) | 2023-01-31 | 2023-08-11 | 주식회사 창의씨앤알 | Plant derived collagen peptide composition and composition comprising the same |
KR102576286B1 (en) | 2023-02-10 | 2023-09-13 | (주)로가 | Manufacturing method of collagen peptides derived from plants |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102299846B1 (en) | Cosmetic composition comprising collagen peptides derived from Hibiscus | |
KR101382758B1 (en) | Collagen peptide composition having good blood transfer properties, and food and drink containing same | |
KR102328107B1 (en) | Food composition comprising collagen peptides derived from Hibiscus | |
JP4470212B2 (en) | Skin improver | |
KR101254403B1 (en) | Method for Preparing Fermented Collagen Peptide | |
KR101822752B1 (en) | Manufacturing method for enzymatic extracts of deer antlerdeer antler containing highly physiologically active ingredients of deer antler and enzymatic extracts of deer antlerdeer antler using the same | |
KR102432924B1 (en) | Extract and composition comprising plant-derived collagen and mucin | |
CA2680544A1 (en) | Skin-whitening agent | |
JP2023532093A (en) | Plant extract containing plant collagen and plant mucin, and method for producing the same | |
KR102576286B1 (en) | Manufacturing method of collagen peptides derived from plants | |
CN113115884A (en) | Composite peptide solid beverage and preparation method and application thereof | |
KR102537089B1 (en) | Producing Method of Collagen Peptide from a plant and Collagen Peptide Produced by the Method | |
KR102365655B1 (en) | Composition for preventing or improving skin wrinkle containing Glycine max Merrill fermented extract | |
KR101485113B1 (en) | A composition of proline based amino acid miture for preventing and curing skin photoaging | |
KR20140086747A (en) | Health Functional Food Composition Comprising Red Ginseng Extract, Benincasa Hispida Extract, and Apios Americana Extract for Improving Skin Beauty | |
KR100946997B1 (en) | A composition containings hydrolysates, second hydrolysates or isolated active peptides of Theragra chalcogramma as an active ingredient | |
KR101839582B1 (en) | Composition for activating cell comprising bran extracts and Method of cell activation | |
KR20200074361A (en) | Composition for skin whitening and composition for ultraviolet-proof comprising the extract of fermented Astragalus membranaceus Bunge | |
KR102537074B1 (en) | Producing Method of Collagen Peptide from a plant, Collagen Peptide Produced by the Method, and Food composition containing the Collagen Peptide | |
KR102252955B1 (en) | Pig placenta hydrolysate and composition for liver protection comprising pig placenta-derived peptide | |
KR20230094329A (en) | Method for preparing low molecular weight pepsin hydrolyzate from flounder shell and use thereof | |
JP2012067061A (en) | Maillard reaction inhibitor and aging improving agent | |
KR102565639B1 (en) | Plant derived collagen peptide composition and composition comprising the same | |
KR102153463B1 (en) | Collagen hydrolysate having high dipeptide contents and process of fabricating thereof and application thereof | |
JP2003009811A (en) | Food composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |